CAR-NK cell therapy: promise and challenges in solid tumors
Over the past few years, cellular immunotherapy has emerged as a promising treatment for certain hematologic cancers, with various CAR-T therapies now widely used in clinical settings. However, challenges related to the production of autologous cell products and the management of CAR-T cell toxicity...
Saved in:
| Main Authors: | Sahar Balkhi, Gaia Zuccolotto, Anna Di Spirito, Antonio Rosato, Lorenzo Mortara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1574742/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors
by: Yunjia Xian, et al.
Published: (2025-06-01) -
Precision sniper for solid tumors: CAR-NK cell therapy
by: Sisi Li, et al.
Published: (2025-07-01) -
CAR-NK cell therapy: latest updates from the 2024 ASH annual meeting
by: Ran Kong, et al.
Published: (2025-03-01) -
Engineering CD5-targeting CAR-NK cells from peripheral blood for the treatment of CD5-positive hematological malignancies
by: Haolong Lin, et al.
Published: (2025-04-01) -
Application and prospects of genetic engineering in CAR-NK cell therapy
by: Caidong Hu, et al.
Published: (2025-05-01)